Skip to main content

Table 2 CMR findings and living status in DMD patients

From: Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function

Patient groups

Alive (n = 102)

Not alive (n = 11)

P-value

Age (years)

14.7 ± 4.8*

19.5 ± 5.9

0.003

Heart rate (bmp)

96 ± 13.9*

110 ± 21

0.003

CMR to death (months)

N/A

10.8 ± 8.5

N/A

LVEF (%)

59.7 ± 7.5*

32 ±13.9

<0.0001

LVEDV/BSA (mL/m2)

73.1 ± 16.9*

128.2 ±46.2

<0.0001

LVM/BSA (g/m2)

51 ± 12.5*

69 ± 11.8

< 0.0001

NPS with LGE

4.5 ± 2.4*

9.6 ± 4.2

<0.0001

Segments with LGE (%)

455/1632 (28%)

106/176 (60%)

N/A

Septal LGE (%)

13/510 (2.5%)

17/55 (31%)

N/A

  1. Abbreviations: BMP Beats per minute, CMR Cardiac Magnetic Resonance Imaging, DMD Duchenne Muscular Dystrophy, LGE Late Gadolinium Enhancement, LVEF Left Ventricular Ejection Fraction, LVEDV/BSA Left Ventricular End-Diastolic Volume Indexed to Body Surface Area, LVM/BSA Left Ventricular Mass Indexed to Body Surface Area, g/m2 Grams Per Meter Square, mL Milliliter, NPS Number of Positive Segments, *Indicates Statistical Significance.